The ATM gene is a target for epigenetic silencing in locally advanced breast cancer (Q34363589)

1 August 2017

The ATM gene is a target for epigenetic silencing in locally advanced breast cancer (English)

1 reference

1 August 2017

0 references

1 reference

Quynh N Vo

1

1 reference

1 August 2017

Wan-Ju Kim

2

1 reference

1 August 2017

Luke Cvitanovic

3

1 reference

1 August 2017

Donald A Boudreau

4

1 reference

1 August 2017

David G Ginzinger

5

1 reference

1 August 2017

Kevin D Brown

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

1 August 2017

1 reference

1 August 2017

23

1 reference

1 August 2017

58

1 reference

1 August 2017

9432-9437

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208092

1 August 2017

0 references

cites work

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

Dominant Negative ATM Mutations in Breast Cancer Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

Epidermal growth factor sensitizes cells to ionizing radiation by down-regulating protein mutated in ataxia-telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

Breast and other cancers in families with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

7 January 2021

Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

7 January 2021

Rapid radiation-induction of ATM protein levels in situ

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

7 January 2021

Site-directed mutagenesis of the ATM promoter: consequences for response to proliferation and ionizing radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

7 January 2021

Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

7 January 2021

Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208092

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208092

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference